IDNA ETF

$29.52
Screen 3,400+ ETFsFind similar ETFs with lower fees

Returns Overview

1 Month
+8.79%
3 Months
+12.82%
6 Months
+40.40%
YTD
+18.32%
1 Year
+37.97%
3 Years
+9.58%
5 Years
-7.33%

Risk Metrics (5-Year)

No risk data available for this ETF

Stress Test Scenarios

How would IDNA have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

+8.79%

3 Months Performance

+12.82%

6 Months Performance

+40.40%

1 Year Performance

+37.97%

Benchmark & Peers

Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index(^NYFSGIB)
This ETF (YTD)
+18.32%
Peer Avg (YTD)
+1.55%
vs Peers
+16.77%

IDNA ETF Performance

IDNA performance across multiple time periods: 1-month 8.79%, YTD 18.32%, 1-year 37.97%, 3-year 9.58%, 5-year -7.33%.

IDNA returns outperform the peer average of 1.55% YTD. With an expense ratio of 0.47%, investors should weigh costs against performance when evaluating this ETF.

IDNA performance comparison shows side-by-side returns with another fund. IDNA alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+8.79%N/A
3 Months+12.82%N/A
6 Months+40.40%N/A
1 Year+37.97%N/A
3 Years+9.58%N/A
5 Years-7.33%N/A

All returns shown are total returns, not annualized